Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in β-thalassemia
The potential of free radical formation in serum of β-thalassemia/ Hb E patients receiving a single oral dose of 25 mg/kg body weight of deferiprone, a bidentate orally active iron chelator, was evaluated using EPR/spin trapping technique. In the presence of ascorbic acid and tert-butylhydroperoxide...
Saved in:
Main Authors: | Totsapol Jirasomprasert, Noppawan Phumala Morales, Lie M G Limenta, Srisuporn Sirijaroonwong, Paveena Yamanont, Prapin Wilairat, Suthat Fucharoen, Udom Chantharaksri |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/27177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Pharmacokinetics of deferiprone in patients with β-thalassaemia: Impact of splenectomy and iron status
by: Lie Michael George Limenta, et al.
Published: (2018) -
UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers
by: Lie Michael George Limenta, et al.
Published: (2018) -
Bioequivalence study of a film-coated tablet of deferiprone in healthy Thai volunteers
by: N. P. Morales, et al.
Published: (2018) -
Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in β-Thalassemia/hemoglobin e patients
by: Supot Rodrat, et al.
Published: (2018) -
Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients
by: Noppawan Phumala Morales, et al.
Published: (2022)